<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>

        References<lb/> 
        <bibl><label>1</label>. <lb/> Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology,<lb/> taxonomy, typing methods, and pathogenicity factors. Clinical microbiology reviews.<lb/> 1998;11(4):589-603.<lb/> </bibl>
        <bibl><label>2</label>. <lb/> Canton R, Coque TM. The CTX-M β-lactamase pandemic. Current opinion in<lb/> microbiology. 2006;9(5):466-75.<lb/> </bibl>
        <bibl><label>3</label>. <lb/> Jacoby GA. AmpC β-lactamases. Clinical microbiology reviews. 2009;22(1):161-<lb/>82.<lb/> </bibl>
        <bibl><label>4</label>. <lb/> Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae:<lb/> here is the storm! Trends in molecular medicine. 2012;18(5):263-72.<lb/> </bibl>
        <bibl><label>5</label>. <lb/> Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing<lb/> Enterobacteriaceae. Emerging infectious diseases. 2011;17(10):1791-8.<lb/> </bibl>
        <bibl><label>6</label>. <lb/> Padilla E, Alonso D, Domenech-Sanchez A, Gomez C, Perez JL, Alberti S, et al.<lb/> Effect of porins and plasmid-mediated AmpC β-lactamases on the efficacy of β-lactams<lb/> in rat pneumonia caused by Klebsiella pneumoniae. Antimicrobial agents and<lb/> chemotherapy. 2006;50(6):2258-60.<lb/> </bibl>
        <bibl><label>7</label>. <lb/> Agyekum A, Fajardo-Lubian A, Ai X, Ginn AN, Zong Z, Guo X, et al.<lb/> Predictability of phenotype in relation to common β-lactam resistance mechanisms in<lb/> Escherichia coli and Klebsiella pneumoniae. Journal of clinical microbiology.<lb/> 2016;54(5):1243-50.<lb/> </bibl>
        <bibl><label>8</label>. <lb/> Alberti S, Rodriquez-Quinones F, Schirmer T, Rummel G, Tomas JM,<lb/> Rosenbusch JP, et al. A porin from Klebsiella pneumoniae: sequence homology, three-<lb/>dimensional model, and complement binding. Infection and immunity. 1995;63(3):903-<lb/>10.<lb/> </bibl>
        <bibl><label>9</label>. <lb/> Hernández-Allés S, Albertí S, Alvarez D, Doménech-Sánchez A, Martínez-<lb/>Martínez L, Gil J, et al. Porin expression in clinical isolates of Klebsiella pneumoniae.<lb/> Microbiology. 1999;145:673-9.<lb/> </bibl>
        <bibl><label>10</label>. <lb/> Domenech-Sánchez A, Pascual A, Suarez AI, Alvarez D, Benedí VJ, Martínez-<lb/>Martínez L. Activity of nine antimicrobial agents against clinical isolates of Klebsiella<lb/> pneumoniae producing extended-spectrum β-lactamases and deficient or not in porins.<lb/> The Journal of antimicrobial chemotherapy. 2000;46(5):858-9.<lb/> </bibl>
        <bibl><label>11</label>. <lb/> Andersson DI, Levin BR. The biological cost of antibiotic resistance. Current<lb/> opinion in microbiology. 1999;2(5):489-93.<lb/> </bibl>
        <bibl><label>12</label>. <lb/> Guo B, Abdelraouf K, Ledesma KR, Nikolaou M, Tam VH. Predicting bacterial<lb/> fitness cost associated with drug resistance. The Journal of antimicrobial chemotherapy.<lb/> 2012;67(4):928-32.<lb/> </bibl>
        <bibl><label>13</label>. <lb/> Marcusson LL, Frimodt-Møller N, Hughes D. Interplay in the selection of<lb/> fluoroquinolone resistance and bacterial fitness. PLoS Pathog. 2009;5(8):e1000541.<lb/> 14.<lb/> Choi MJ, Ko KS. Loss of hypermucoviscosity and increased fitness cost in<lb/> colistin-resistant Klebsiella pneumoniae sequence type 23 strains. Antimicrobial agents<lb/> and chemotherapy. 2015;59(11):6763-73.<lb/> </bibl>
        <bibl><label>15</label>. <lb/> Pagès JM, James CE, Winterhalter M. The porin and the permeating antibiotic:<lb/> a selective diffusion barrier in Gram-negative bacteria. Nature reviews Microbiology.<lb/> 2008;6(12):893-903.<lb/> </bibl>
        <bibl><label>16</label>. <lb/> King T, Ishihama A, Kori A, Ferenci T. A regulatory trade-off as a source of<lb/> strain variation in the species Escherichia coli. Journal of bacteriology.<lb/> 2004;186(17):5614-20.<lb/> </bibl>
        <bibl><label>17</label>. <lb/> Ferenci T. Maintaining a healthy SPANC balance through regulatory and<lb/> mutational adaptation. Molecular microbiology. 2005;57(1):1-8.<lb/> </bibl>
        <bibl><label>18</label>. <lb/> Ferenci T, Phan K. How porin heterogeneity and trade-offs affect the antibiotic<lb/> susceptibility of Gram-negative bacteria. Genes (Basel). 2015;6(4):1113-24.<lb/> </bibl>
        <bibl><label>19</label>. <lb/> Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to<lb/> reverse resistance? Nature reviews Microbiology. 2010;8(4):260-71.<lb/> </bibl>
        <bibl><label>20</label>. <lb/> Crowley B, Benedi VJ, Domenech-Sanchez A. Expression of SHV-2 β-lactamase<lb/> and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased<lb/> resistance to cephalosporins and carbapenems. Antimicrobial agents and<lb/> chemotherapy. 2002;46(11):3679-82.<lb/> </bibl>
        <bibl><label>21</label>. <lb/> Agyekum A, Fajardo-Lubi A, Xiaoman A, Ginn AN, Zong Z, Guo X, et al.<lb/> Predictability of phenotype in relation to common beta-lactam resistance mechanisms in<lb/> Escherichia coli and Klebsiella pneumoniae. Journal of clinical microbiology. 2016.<lb/></bibl> 
        <bibl><label>22</label>. <lb/> Woodcock DM, Crowther PJ, Doherty J, Jefferson S, DeCruz E, Noyer-Weidner<lb/> M, et al. Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine<lb/> methylation in plasmid and phage recombinants. Nucleic acids research.<lb/> 1989;17(9):3469-78.<lb/> </bibl>
        <bibl><label>23</label>. <lb/> Crepin S, Harel J, Dozois CM. Chromosomal complementation using Tn7<lb/> transposon vectors in Enterobacteriaceae. Applied and environmental microbiology.<lb/> 2012;78(17):6001-8.<lb/> </bibl>
        <bibl><label>24</label>. <lb/> Ogunniyi AD, Kotlarski I, Morona R, Manning PA. Role of SefA subunit protein<lb/> of SEF14 fimbriae in the pathogenesis of Salmonella enterica serovar Enteritidis.<lb/> Infection and immunity. 1997;65(2):708-17.<lb/> </bibl>
        <bibl><label>25</label>. <lb/> Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in<lb/> Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97(12):6640-<lb/>5.<lb/> </bibl>
        <bibl><label>26</label>. <lb/> Murphy KC, Campellone KG. Lambda Red-mediated recombinogenic<lb/> engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol Biol.<lb/> 2003;4:11.<lb/> </bibl>
        <bibl><label>27</label>. <lb/> CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that<lb/> grow aerobically. 9th edition ed: Clinical Laboratory Standards Institute, Wayne, PA;<lb/> 2012.<lb/> </bibl>
        <bibl><label>28</label>. <lb/> EUCAST. Breakpoint tables for the interpretation of MICs and zone diameters:<lb/> European Committee on Antimicrobial Susceptibility Testing, Váxjö, Sweden; 2015.<lb/> </bibl>
        <bibl><label>29</label>. <lb/> CLSI. Performance standards for antimicrobial susceptibility testing; Twenty-<lb/>fourth informational supplement2014.<lb/> </bibl>
        <bibl><label>30</label>. <lb/> Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L,<lb/> Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant<lb/> Acinetobacter baumannii. Journal of clinical microbiology. 2007;45(2):453-60.<lb/> </bibl>
        <bibl><label>31</label>. <lb/> Partridge SR, Ellem JA, Tetu SG, Zong Z, Paulsen IT, Iredell JR. Complete<lb/> sequence of pJIE143, a pir-type plasmid carrying ISEcp1-bla CTX-M-15 from an<lb/> Escherichia coli ST131 isolate. Antimicrobial agents and chemotherapy.<lb/> 2011;55(12):5933-5.<lb/> </bibl>
        <bibl><label>32</label>. <lb/> Partridge SR, Ginn AN, Paulsen IT, Iredell JR. pEl1573 carrying bla IMP-4, from<lb/>  Sydney, Australia, is closely related to other IncL/M plasmids. Antimicrobial agents<lb/> and chemotherapy. 2012;56(11):6029-32.<lb/> </bibl>
        <bibl><label>33</label>. <lb/> Partridge SR, Ginn AN, Wiklendt AM, Ellem J, Wong JS, Ingram P, et al.<lb/> Emergence of bla KPC carbapenemase genes in Australia. Int J Antimicrob Agents.<lb/> 2015;45(2):130-6.<lb/> </bibl>
        <bibl><label>34</label>. <lb/> Zong Z, Partridge SR, Thomas L, Iredell JR. Dominance of bla CTX-M within an<lb/> Australian extended-spectrum β-lactamase gene pool. Antimicrobial agents and<lb/> chemotherapy. 2008;52(11):4198-202.<lb/> </bibl>
        <bibl><label>35</label>. <lb/> Espedido BA, Partridge SR, Iredell JR. bla IMP-4 in different genetic contexts in<lb/> Enterobacteriaceae isolates from Australia. Antimicrobial agents and chemotherapy.<lb/> 2008;52(8):2984-7.<lb/> </bibl>
        <bibl><label>36</label>. <lb/> Barton BM, Harding GP, Zuccarelli AJ. A general method for detecting and<lb/> sizing large plasmids. Analytical biochemistry. 1995;226(2):235-40.<lb/> </bibl>
        <bibl><label>37</label>. <lb/> Partridge SR, Zong Z, Iredell JR. Recombination in IS26 and Tn2 in the<lb/> evolution of multiresistance regions carrying bla CTX-M-15 on conjugative IncF plasmids<lb/> from Escherichia coli. Antimicrobial agents and chemotherapy. 2011;55(11):4971-8.<lb/> </bibl>
        <bibl><label>38</label>. <lb/> Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO. Rapid microprocedure<lb/> for isolating detergent-insoluble outer membrane proteins from Haemophilus species.<lb/> Journal of clinical microbiology. 1986;24(3):330-2.<lb/> </bibl>
        <bibl><label>39</label>. <lb/> Rasheed JK, Anderson GJ, Yigit H, Queenan AM, Domenech-Sanchez A,<lb/> Swenson JM, et al. Characterization of the extended-spectrum β-lactamase reference<lb/> strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme<lb/> SHV-18. Antimicrobial agents and chemotherapy. 2000;44(9):2382-8.<lb/> </bibl>
        <bibl><label>40</label>. <lb/> Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-<lb/>time quantitative PCR and the 2(-C(T)) Method. Methods. 2001;25(4):402-8.<lb/> </bibl>
        <bibl><label>41</label>. <lb/> Knopp M, Andersson DI. Amelioration of the fitness costs of antibiotic resistance<lb/> due to reduced outer membrane permeability by upregulation of alternative porins.<lb/> Molecular biology and evolution. 2015;32(12):3252-63.<lb/> </bibl>
        <bibl><label>42</label>. <lb/> Olivares J, Alvarez-Ortega C, Linares JF, Rojo F, Kohler T, Martinez JL.<lb/> Overproduction of the multidrug efflux pump MexEF-OprN does not impair<lb/> Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in<lb/> bacterial regulatory networks. Environmental microbiology. 2012;14(8):1968-81.<lb/> </bibl>
        <bibl><label>43</label>. <lb/> Nevola JJ, Stocker BA, Laux DC, Cohen PS. Colonization of the mouse intestine<lb/> by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective<lb/> mutants. Infection and immunity. 1985;50(1):152-9.<lb/> </bibl>
        <bibl><label>44</label>. <lb/> Favre-Bonte S, Licht TR, Forestier C, Krogfelt KA. Klebsiella pneumoniae<lb/> capsule expression is necessary for colonization of large intestines of streptomycin-<lb/>treated mice. Infection and immunity. 1999;67(11):6152-6.<lb/> </bibl>
        <bibl><label>45</label>. <lb/> Schjorring S, Struve C, Krogfelt KA. Transfer of antimicrobial resistance<lb/> plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine. The<lb/> Journal of antimicrobial chemotherapy. 2008;62(5):1086-93.<lb/> </bibl>
        <bibl><label>46</label>. <lb/> Schjørring S, Struve C, Krogfelt KA. Transfer of antimicrobial resistance<lb/> plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine. The<lb/> Journal of antimicrobial chemotherapy. 2008;62(5):1086-93.<lb/> </bibl>
        <bibl><label>47</label>. <lb/> Chaves J, Ladona MG, Segura C, Coira A, Reig R, Ampurdanes C. SHV-1 beta-<lb/>lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella<lb/> pneumoniae. Antimicrobial agents and chemotherapy. 2001;45(10):2856-61.<lb/> </bibl>
        <bibl><label>48</label>. <lb/> Haeggman S, Lofdahl S, Paauw A, Verhoef J, Brisse S. Diversity and evolution<lb/> of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae.<lb/> Antimicrobial agents and chemotherapy. 2004;48(7):2400-8.<lb/> </bibl>
        <bibl><label>49</label>. <lb/> Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical<lb/> challenges of new -lactamases from Gram-negative bacteria. Annual review of<lb/> microbiology. 2011;65:455-78.<lb/> </bibl>
        <bibl><label>50</label>. <lb/> Tomás JM, Ciurana B, Jofre JT. New, simple medium for selective, differential<lb/> recovery of Klebsiella spp. Applied and environmental microbiology. 1986;51(6):1361-3.<lb/> </bibl>
        <bibl><label>51</label>. <lb/> Lawlor MS, Hsu J, Rick PD, Miller VL. Identification of Klebsiella pneumoniae<lb/> virulence determinants using an intranasal infection model. Molecular microbiology.<lb/> 2005;58(4):1054-73.<lb/> </bibl>
        <bibl><label>52</label>. <lb/> Struve C, Bojer M, Krogfelt KA. Characterization of Klebsiella pneumoniae type<lb/> 1 fimbriae by detection of phase variation during colonization and infection and impact<lb/> on virulence. Infection and immunity. 2008;76(9):4055-65.<lb/> </bibl>
        <bibl><label>53</label>. <lb/> Renois F, Jacques J, Guillard T, Moret H, Pluot M, Andreoletti L, et al.<lb/> Preliminary investigation of a mice model of Klebsiella pneumoniae subsp. ozaenae<lb/> induced pneumonia. Microbes and infection. 2011;13(12-13):1045-51.<lb/> </bibl>
        <bibl><label>54</label>. <lb/> Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, et al.<lb/> SWISS-MODEL: modelling protein tertiary and quaternary structure using<lb/> evolutionary information. Nucleic acids research. 2014;42(Web Server issue):W252-8.<lb/> </bibl>
        <bibl><label>55</label>. <lb/> Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, et al.<lb/> MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.<lb/> Nucleic acids research. 2007;35(Web Server issue):W375-83.<lb/> </bibl>
        <bibl><label>56</label>. <lb/> Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ,<lb/> et al. MolProbity: all-atom structure validation for macromolecular crystallography.<lb/> Acta crystallographica Section D, Biological crystallography. 2010;66(Pt 1):12-21.<lb/> </bibl>
        <bibl><label>57</label>. <lb/> Bowie JU, Luthy R, Eisenberg D. A method to identify protein sequences that<lb/> fold into a known three-dimensional structure. Science. 1991;253(5016):164-70.<lb/> </bibl>
        <bibl><label>58</label>. <lb/> Luthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-<lb/>dimensional profiles. Nature. 1992;356(6364):83-5.<lb/> </bibl>
        <bibl><label>59</label>. <lb/> Schrodinger L. The PyMOL Molecular Graphics System, Version 2.1.1. 2015.<lb/> </bibl>
        <bibl><label>60</label>. <lb/> Lee RS, Seemann T, Heffernan H, Kwong JC, Goncalves da Silva A, Carter GP,<lb/> et al. Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in<lb/> New Zealand. The Journal of antimicrobial chemotherapy. 2018;73(2):353-64.<lb/></bibl>
        <bibl><label>61</label>. <lb/> Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al.<lb/> SPAdes: a new genome assembly algorithm and its applications to single-cell<lb/> sequencing. J Comput Biol. 2012;19(5):455-77.<lb/> </bibl>
        <bibl><label>62</label>. <lb/> Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment<lb/> with gene gain, loss and rearrangement. PloS one. 2010;5(6):e11147.<lb/> </bibl>
        <bibl><label>63</label>. <lb/> Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics.<lb/> 2014;30(14):2068-9.<lb/> </bibl>
        <bibl><label>64</label>. <lb/> Lam MMC, Wick RR, Wyres KL, Gorrie C, Judd LM, Brisse S, et al. Frequent<lb/> emergence of pathogenic lineages of Klebsiella pneumoniae via mobilisation of<lb/> yersiniabactin and colibactin. bioRxiv. 2017.<lb/> </bibl>
        <bibl><label>65</label>. <lb/> Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MT, et al. Roary:<lb/> rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691-3.<lb/> </bibl>
        <bibl><label>66</label>. <lb/> Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and<lb/> effective stochastic algorithm for estimating maximum-likelihood phylogenies.<lb/> Molecular biology and evolution. 2015;32(1):268-74.<lb/> </bibl>
        <bibl><label>67</label>. <lb/> Hadfield J, Croucher NJ, Goater RJ, Abudahab K, Aanensen DM, Harris SR.<lb/> handango: an interactive viewer for bacterial population genomics. Bioinformatics.<lb/> 2017.<lb/> </bibl>
        <bibl><label>68</label>. <lb/> Haanperä M, Forssten SD, Huovinen P, Jalava J. Typing of SHV extended-<lb/>spectrum β-lactamases by pyrosequencing in Klebsiella pneumoniae strains with<lb/> chromosomal SHV β-lactamase. Antimicrobial agents and chemotherapy.<lb/> 2008;52(7):2632-5.<lb/> </bibl>
        <bibl><label>69</label>. <lb/> Babini GS, Livermore DM. Are SHV β-lactamases universal in Klebsiella<lb/> pneumoniae? Antimicrobial agents and chemotherapy. 2000;44(8):2230.<lb/> </bibl>
        <bibl><label>70</label>. <lb/> Haeggman S, Löfdahl S, Paauw A, Verhoef J, Brisse S. Diversity and evolution of<lb/> the class A chromosomal β-lactamase gene in Klebsiella pneumoniae. Antimicrobial<lb/> agents and chemotherapy. 2004;48(7):2400-8.<lb/> </bibl>
        <bibl><label>71</label>. <lb/> Chaves J, Ladona MG, Segura C, Coira A, Reig R, Ampurdanés C. SHV-1 β-<lb/>lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella<lb/> pneumoniae. Antimicrobial agents and chemotherapy. 2001;45(10):2856-61.<lb/> </bibl>
        <bibl><label>72</label>. <lb/> EUCAST. The European Committee on Antimicrobial Susceptibility Testing.<lb/> Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0.<lb/> www.eucast.org: European Committee on Antimicrobial Susceptibility Testing; 2018.<lb/> </bibl>
        <bibl><label>73</label>. <lb/> CLSI. M100-S24. Performance Standards for Antimicrobial Susceptibility Testing;<lb/> Twenty-Fourth Informational Supplement. Clinical and Laboratory Standards Institute;<lb/> Wayne, PA. 2014.<lb/> </bibl>
        <bibl><label>74</label>. <lb/> Garcia-Sureda L, Juan C, Domenech-Sanchez A, Alberti S. Role of Klebsiella<lb/> pneumoniae LamB Porin in antimicrobial resistance. Antimicrobial agents and<lb/> chemotherapy. 2011;55(4):1803-5.<lb/> </bibl>
        <bibl><label>75</label>. <lb/> Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem<lb/> resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1<lb/> β-lactamase production, porin OmpK35/36 insertional inactivation, and down-<lb/>regulation of the phosphate transport porin PhoE. Antimicrobial agents and<lb/> chemotherapy. 2006;50(10):3396-406.<lb/> </bibl>
        <bibl><label>76</label>. <lb/> Doménech-Sánchez A, Martínez-Martínez L, Hernández-Allés S, del Carmen<lb/> Conejo M, Pascual A, Tomás JM, et al. Role of Klebsiella pneumoniae OmpK35 porin in<lb/> antimicrobial resistance. Antimicrobial agents and chemotherapy. 2003;47(10):3332-5.<lb/> </bibl>
        <bibl><label>77</label>. <lb/> Garcia-Sureda L, Domenech-Sanchez A, Barbier M, Juan C, Gasco J, Alberti S.<lb/> OmpK26, a novel porin associated with carbapenem resistance in Klebsiella<lb/> pneumoniae. Antimicrobial agents and chemotherapy. 2011;55(10):4742-7.<lb/> </bibl>
        <bibl><label>78</label>. <lb/> Tsai YK, Fung CP, Lin JC, Chen JH, Chang FY, Chen TL, et al. Klebsiella<lb/> pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both<lb/> antimicrobial resistance and virulence. Antimicrobial agents and chemotherapy.<lb/> 2011;55(4):1485-93.<lb/> </bibl>
        <bibl><label>79</label>. <lb/> March C, Cano V, Moranta D, Llobet E, Perez-Gutierrez C, Tomas JM, et al.<lb/> Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with<lb/> phagocytes. PloS one. 2013;8(2):e56847.<lb/> </bibl>
        <bibl><label>80</label>. <lb/> Pitout JD, Sanders CC, Sanders WE, Jr. Antimicrobial resistance with focus on<lb/> β-lactam resistance in Gram-negative bacilli. Am J Med. 1997;103(1):51-9.<lb/> </bibl>
        <bibl><label>81</label>. <lb/> Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE, Jr., Archibald<lb/> LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United<lb/> States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial<lb/> Resistance Epidemiology (ICARE) hospitals. Clinical infectious diseases : an official<lb/> publication of the Infectious Diseases Society of America. 1999;29(2):245-52.<lb/> </bibl>
        <bibl><label>82</label>. <lb/> Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al.<lb/> NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-<lb/>associated infections: annual summary of data reported to the National Healthcare<lb/> Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection<lb/> control and hospital epidemiology : the official journal of the Society of Hospital<lb/> Epidemiologists of America. 2008;29(11):996-1011.<lb/> </bibl>
        <bibl><label>83</label>. <lb/> Wollheim C, Guerra IM, Conte VD, Hoffman SP, Schreiner FJ, Delamare AP, et<lb/> al. Nosocomial and community infections due to class A extended-spectrum beta-<lb/>lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil. The Brazilian journal of infectious diseases : an official publication of the Brazilian<lb/> Society of Infectious Diseases. 2011;15(2):138-43.<lb/> </bibl>
        <bibl><label>84</label>. <lb/> Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms<lb/> disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp.<lb/> clinical isolates from the UK. The Journal of antimicrobial chemotherapy.<lb/> 2009;63(4):659-67.<lb/> </bibl>
        <bibl><label>85</label>. <lb/> Chudácková E, Bergerová T, Fajfrlík K, Cervená D, Urbásková P, Empel J, et<lb/> al. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5<lb/> and/or DHA-1 β-lactamases in a Czech hospital. FEMS microbiology letters.<lb/> 2010;309(1):62-70.<lb/> </bibl>
        <bibl><label>86</label>. <lb/> Nikaido H, Rosenberg EY. Effect on solute size on diffusion rates through the<lb/> transmembrane pores of the outer membrane of Escherichia coli. J Gen Physiol.<lb/> 1981;77(2):121-35.<lb/> </bibl>
        <bibl><label>87</label>. <lb/> Jaffe A, Chabbert YA, Semonin O. Role of porin proteins OmpF and OmpC in<lb/> the permeation of β-lactams. Antimicrobial agents and chemotherapy. 1982;22(6):942-8.<lb/> </bibl>
        <bibl><label>88</label>. <lb/> Nitzan Y, Deutsch EB, Pechatnikov I. Diffusion of β-lactam antibiotics through<lb/> oligomeric or monomeric porin channels of some Gram-negative bacteria. Curr<lb/> Microbiol. 2002;45(6):446-55.<lb/> </bibl>
        <bibl><label>89</label>. <lb/> Sugawara E, Kojima S, Nikaido H. Klebsiella pneumoniae major porins OmpK35<lb/> and OmpK36 allow more efficient diffusion of β-lactams than their Escherichia coli<lb/> homologs OmpF and OmpC. Journal of bacteriology. 2016;198(23):3200-8.<lb/> </bibl>
        <bibl><label>90</label>. <lb/> Chen JH, Siu LK, Fung CP, Lin JC, Yeh KM, Chen TL, et al. Contribution of<lb/> outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella<lb/> pneumoniae. The Journal of antimicrobial chemotherapy. 2010;65(5):986-90.<lb/> </bibl>
        <bibl><label>91</label>. <lb/> Tsai YK, Liou CH, Fung CP, Lin JC, Siu LK. Single or in combination<lb/> antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied<lb/> susceptibility to different carbapenems. PloS one. 2013;8(11):e79640.<lb/> </bibl>
        <bibl><label>92</label>. <lb/> Bedikian A, Okamoto MP, Nakahiro RK, Farino J, Heseltine PN, Appleman<lb/> MD, et al. Pharmacokinetics of meropenem in patients with intra-abdominal infections.<lb/> Antimicrobial agents and chemotherapy. 1994;38(1):151-4.<lb/> </bibl>
        <bibl><label>93</label>. <lb/> Condon RE, Walker AP, Hanna CB, Greenberg RN, Broom A, Pitkin D.<lb/> Penetration of meropenem in plasma and abdominal tissues from patients undergoing<lb/> intraabdominal surgery. Clinical infectious diseases : an official publication of the<lb/> Infectious Diseases Society of America. 1997;24 Suppl 2:S181-3.<lb/> </bibl>
        <bibl><label>94</label>. <lb/> Hughes D, Andersson DI. Evolutionary consequences of drug resistance: shared<lb/> principles across diverse targets and organisms. Nature reviews Genetics.<lb/> 2015;16(8):459-71.<lb/> </bibl>
        <bibl><label>95</label>. <lb/> Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem<lb/> resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1<lb/> -lactamase production, porin OmpK35/36 insertional inactivation, and down-<lb/>regulation of the phosphate transport porin phoE. Antimicrobial agents and<lb/> chemotherapy. 2006;50(10):3396-406.<lb/> </bibl>
        <bibl><label>96</label>. <lb/> Wise MG, Horvath E, Young K, Sahm DF, Kazmierczak KM. Global survey of<lb/> 
        Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking<lb/> carbapenemases. Journal of medical microbiology. 2018;67(3):289-95.<lb/> </bibl>
        <bibl><label>97</label>. <lb/> De E, Baslé A, Jaquinod M, Saint N, Malléa M, Molle G, et al. A new mechanism<lb/> of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the<lb/> major porin. Molecular microbiology. 2001;41(1):189-98.<lb/> </bibl>
        <bibl><label>98</label>. <lb/> Olesky M, Zhao S, Rosenberg RL, Nicholas RA. Porin-mediated antibiotic<lb/> resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB<lb/> proteins with penB mutations. Journal of bacteriology. 2006;188(7):2300-8.<lb/> </bibl>
        <bibl><label>99</label>. <lb/> Lou H, Chen M, Black SS, Bushell SR, Ceccarelli M, Mach T, et al. Altered<lb/> antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-<lb/>drug resistant E. coli. PloS one. 2011;6(10):e25825.<lb/> </bibl>
        <bibl><label>100</label>. Bredin J, Saint N, Mallea M, De E, Molle G, Pagès JM, et al. Alteration of pore<lb/> properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3<lb/> region. Biochem J. 2002;363(Pt 3):521-8.<lb/> </bibl>
        <bibl><label>101</label>. Thiolas A, Bornet C, Davin-Regli A, Pagès JM, Bollet C. Resistance to imipenem,<lb/> cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter<lb/> aerogenes. Biochem Biophys Res Commun. 2004;317(3):851-6.<lb/> </bibl>
        <bibl><label>102</label>. Sugawara E, Kojima S, Nikaido H. Klebsiella pneumoniae major porins OmpK35<lb/> and OmpK36 allow more efficient diffusion of -Lactams than their Escherichia coli<lb/> homologs OmpF and OmpC. Journal of bacteriology. 2016;198(23):3200-8.<lb/> </bibl>
        <bibl><label>103</label>. Bornet C, Saint N, Fetnaci L, Dupont M, Davin-Regli A, Bollet C, et al. Omp35,<lb/> a new Enterobacter aerogenes porin involved in selective susceptibility to<lb/> cephalosporins. Antimicrobial agents and chemotherapy. 2004;48(6):2153-8.<lb/> </bibl>
        <bibl><label>104</label>. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria:<lb/> the role of high-risk clones in the dissemination of antibiotic resistance. FEMS<lb/> microbiology reviews. 2011;35(5):736-55.<lb/> </bibl>
        <bibl><label>105</label>. Wright LL, Turton JF, Livermore DM, Hopkins KL, Woodford N. Dominance<lb/> of international &apos;high-risk clones&apos; among metallo-beta-lactamase-producing<lb/> Pseudomonas aeruginosa in the UK. The Journal of antimicrobial chemotherapy.<lb/> 2015;70(1):103-10.<lb/> </bibl>
        <bibl><label>106</label>. Andersson DI, Hughes D. Microbiological effects of sublethal levels of<lb/> antibiotics. Nature reviews Microbiology. 2014;12(7):465-78.<lb/> </bibl>
        <bibl><label>107</label>. Yang Y, Song W, Lin H, Wang W, Du L, Xing W. Antibiotics and antibiotic<lb/> resistance genes in global lakes: A review and meta-analysis. Environment<lb/> international. 2018;116:60-73.<lb/> </bibl>
        <bibl><label>108</label>. Pulzova L, Navratilova L, Comor L. Alterations in outer membrane<lb/> permeability favor drug-resistant phenotype of Klebsiella pneumoniae. Microbial drug<lb/> resistance. 2017;23(4):413-20.<lb/> </bibl>
        <bibl><label>109</label>. Elena SF, Lenski RE. Evolution experiments with microorganisms: the dynamics<lb/> and genetic bases of adaptation. Nature reviews Genetics. 2003;4(6):457-69.<lb/> </bibl>
        <bibl><label>110</label>. Harder KJ, Nikaido H, Matsuhashi M. Mutants of Escherichia coli that are<lb/> resistant to certain beta-lactam compounds lack the ompF porin. Antimicrobial agents<lb/> and chemotherapy. 1981;20(4):549-52.<lb/> </bibl>
        <bibl><label>111</label>. Hasegawa Y, Yamada H, Mizushima S. Interactions of outer membrane proteins<lb/> O-8 and O-9 with peptidoglycan sacculus of Escherichia coli K-12. Journal of<lb/> biochemistry. 1976;80(6):1401-9.<lb/> </bibl>
        <bibl><label>112</label>. Matsubara M, Kitaoka SI, Takeda SI, Mizuno T. Tuning of the porin expression<lb/> under anaerobic growth conditions by his-to-Asp cross-phosphorelay through both the<lb/> EnvZ-osmosensor and ArcB-anaerosensor in Escherichia coli. Genes to cells : devoted<lb/> to molecular &amp; cellular mechanisms. 2000;5(7):555-69.<lb/> </bibl>
        <bibl><label>113</label>. Heyde M, Portalier R. Regulation of major outer membrane porin proteins of<lb/> Escherichia coli K 12 by pH. Molecular &amp; general genetics : MGG. 1987;208(3):511-7.<lb/> </bibl>
        <bibl><label>114</label>. Giraud A, Arous S, De Paepe M, Gaboriau-Routhiau V, Bambou JC, Rakotobe<lb/> S, et al. Dissecting the genetic components of adaptation of Escherichia coli to the mouse<lb/> gut. PLoS genetics. 2008;4(1):e2.<lb/> structure based on previous studies. (1, 2). Red boxes, residues involved in the pore eyelet<lb/> based on (3). Black box, L3 variants.<lb/> </bibl>

        <bibl><label>1</label>. Cowan SW, Schirmer T, Rummel G, Steiert M, Ghosh R, Pauptit RA, et al. Crystal<lb/> structures explain functional properties of two E. coli porins. Nature. 1992;358(6389):727-33.<lb/> </bibl>
        <bibl><label>2</label>. Domenech-Sanchez A, Hernandez-Alles S, Martinez-Martinez L, Benedi VJ,<lb/> Alberti S. Identification and characterization of a new porin gene of Klebsiella pneumoniae:<lb/> its role in β-lactam antibiotic resistance. J Bacteriol. 1999;181(9):2726-32.<lb/> </bibl>
        <bibl><label>3</label>. Bornet C, Saint N, Fetnaci L, Dupont M, Davin-Regli A, Bollet C, et al. Omp35, a<lb/> new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins.<lb/> Antimicrob Agents Chemother. 2004;48(6):2153-8.</bibl>

        </listBibl>
    </text>
</tei>

